Airain ltd decreased its stake in Danaher Corporation (NYSE:DHR) by 18.3% during the first quarter, according to its most recent disclosure with the SEC. The firm owned 6,102 shares of the conglomerate’s stock after selling 1,363 shares during the period. Airain ltd’s holdings in Danaher Corporation were worth $522,000 as of its most recent filing with the SEC.
Other large investors have also modified their holdings of the company. Peddock Capital Advisors LLC boosted its stake in shares of Danaher Corporation by 17.4% in the first quarter. Peddock Capital Advisors LLC now owns 1,224 shares of the conglomerate’s stock valued at $105,000 after buying an additional 181 shares in the last quarter. Motco boosted its position in shares of Danaher Corporation by 26.7% in the first quarter. Motco now owns 1,848 shares of the conglomerate’s stock worth $158,000 after buying an additional 390 shares in the last quarter. Baystate Wealth Management LLC boosted its position in shares of Danaher Corporation by 3.3% in the first quarter. Baystate Wealth Management LLC now owns 1,900 shares of the conglomerate’s stock worth $163,000 after buying an additional 60 shares in the last quarter. Integrated Investment Consultants LLC boosted its position in shares of Danaher Corporation by 22.1% in the first quarter. Integrated Investment Consultants LLC now owns 2,168 shares of the conglomerate’s stock worth $185,000 after buying an additional 393 shares in the last quarter. Finally, Cedar Wealth Management LLC boosted its position in shares of Danaher Corporation by 5.3% in the first quarter. Cedar Wealth Management LLC now owns 2,286 shares of the conglomerate’s stock worth $196,000 after buying an additional 115 shares in the last quarter. Institutional investors own 76.34% of the company’s stock.
Shares of Danaher Corporation (DHR) traded up 0.33% during mid-day trading on Friday, hitting $81.43. 3,018,302 shares of the stock were exchanged. The stock has a market capitalization of $56.57 billion, a P/E ratio of 25.99 and a beta of 1.05. The stock’s 50 day moving average price is $84.11 and its 200-day moving average price is $84.25. Danaher Corporation has a 12-month low of $75.71 and a 12-month high of $88.01.
Danaher Corporation (NYSE:DHR) last posted its quarterly earnings results on Thursday, July 20th. The conglomerate reported $0.99 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.97 by $0.02. Danaher Corporation had a net margin of 12.63% and a return on equity of 11.15%. The business had revenue of $4.51 billion during the quarter, compared to the consensus estimate of $4.50 billion. During the same quarter last year, the firm posted $0.90 EPS. Danaher Corporation’s revenue was up 6.3% compared to the same quarter last year. On average, equities research analysts expect that Danaher Corporation will post $3.95 EPS for the current fiscal year.
The firm also recently declared a quarterly dividend, which was paid on Friday, July 28th. Investors of record on Friday, June 30th were given a $0.14 dividend. This represents a $0.56 annualized dividend and a yield of 0.69%. The ex-dividend date of this dividend was Wednesday, June 28th. Danaher Corporation’s payout ratio is currently 17.83%.
COPYRIGHT VIOLATION WARNING: “Danaher Corporation (NYSE:DHR) Position Reduced by Airain ltd” was originally reported by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are reading this piece on another website, it was stolen and republished in violation of US & international trademark & copyright laws. The correct version of this piece can be accessed at https://www.chaffeybreeze.com/2017/07/29/airain-ltd-sells-1363-shares-of-danaher-corporation-nysedhr-updated-updated-updated.html.
A number of brokerages recently issued reports on DHR. Royal Bank Of Canada restated a “sector perform” rating and set a $88.00 price objective (down previously from $89.00) on shares of Danaher Corporation in a report on Friday, April 21st. BidaskClub cut shares of Danaher Corporation from a “hold” rating to a “sell” rating in a report on Tuesday. Zacks Investment Research cut shares of Danaher Corporation from a “buy” rating to a “hold” rating in a report on Thursday. Citigroup Inc. set a $96.00 price objective on shares of Danaher Corporation and gave the company a “buy” rating in a report on Friday, July 21st. Finally, Janney Montgomery Scott cut shares of Danaher Corporation from a “buy” rating to a “neutral” rating in a report on Wednesday, June 7th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have issued a buy rating and one has assigned a strong buy rating to the company. The stock currently has a consensus rating of “Buy” and an average target price of $91.76.
In related news, SVP Angela S. Lalor sold 10,815 shares of Danaher Corporation stock in a transaction on Tuesday, May 23rd. The shares were sold at an average price of $84.16, for a total value of $910,190.40. Following the completion of the sale, the senior vice president now owns 39,020 shares of the company’s stock, valued at approximately $3,283,923.20. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, insider William King sold 7,458 shares of the firm’s stock in a transaction on Friday, July 21st. The shares were sold at an average price of $82.97, for a total value of $618,790.26. Following the transaction, the insider now owns 18,245 shares in the company, valued at $1,513,787.65. The disclosure for this sale can be found here. In the last three months, insiders sold 28,851 shares of company stock valued at $2,407,272. 12.20% of the stock is currently owned by insiders.
About Danaher Corporation
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with MarketBeat.com's FREE daily email newsletter.